Clinical trials
Endophthalmitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 12 |
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Withdrawn | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federal University of São Paulo | 3 |
| University of Campinas, Brazil | 3 |
| Benha University | 2 |
| National Eye Institute (NEI) | 2 |
| Universidade Federal de Pernambuco | 2 |
| Asociación para Evitar la Ceguera en México | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assiut University | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| Biogen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endophthalmitis | 57 |
| Cataract | 7 |
| Eye Infections | 5 |
| Inflammation | 5 |
| Uveitis | 4 |
| Keratitis | 3 |
| Eye Pain | 2 |
| Macular Degeneration | 2 |
| Bacterial Infections | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.